MAXIMUM — Class II drug recall D-0387-2026
Ongoing recall by HTO Nevada Inc. dba Kirkman, reported 2026-03-11, distributed nationwide. Stability Data Does Not Support Expiry Date.
| Recall number | D-0387-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | HTO Nevada Inc. dba Kirkman, Lake Oswego, OR, United States |
| Recall initiated | 2026-02-18 |
| Classified | 2026-03-05 |
| Reported by FDA | 2026-03-11 |
| Distributed | Nationwide (US) |
| Quantity | 243 bottles |
| Reason classes | specification failure |
| Lot numbers | 795CP-0005 |
| Expiration dates | 2026-06-30 |
Product
MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015.
Reason for recall
Stability Data Does Not Support Expiry Date.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0387-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.